Suppr超能文献

澳大利亚人群中,孕妇血清 25-羟维生素 D 浓度在早孕期对后续妊娠结局的影响。

Effects of maternal serum 25-hydroxyvitamin D concentrations in the first trimester on subsequent pregnancy outcomes in an Australian population.

机构信息

Clinical and Population Perinatal Health Research, Kolling Institute of Medical Research (FJS, CLR, CG, CSA, AZK, AWA, JMM, and NN); the Sydney School of Public Health (JMS), University of Sydney, Sydney, Australia; and Fetal Maternal Medicine, Royal North Shore Hospital, St Leonards, Australia (VT).

出版信息

Am J Clin Nutr. 2014 Feb;99(2):287-95. doi: 10.3945/ajcn.113.065672. Epub 2013 Nov 20.

Abstract

BACKGROUND

Low serum 25-hydroxyvitamin D [25(OH)D] concentrations during pregnancy have been associated with adverse pregnancy outcomes in a few studies but not in other studies.

OBJECTIVES

We assessed the serum 25(OH)D concentration at 10-14 wk of pregnancy and its association with adverse pregnancy outcomes and examined the predictive accuracy.

DESIGN

In this nested case-control study, we measured serum 25(OH)D in 5109 women with singleton pregnancies who were attending first-trimester screening in New South Wales, Australia. Multivariate logistic regression was conducted to examine the association between low 25(OH)D concentrations and adverse pregnancy outcomes (small for gestational age, preterm birth, preeclampsia, gestational diabetes, miscarriage, and stillbirth). The predictive accuracy of models was assessed.

RESULTS

The median (IQR) 25(OH)D concentration for the total population was 56.4 nmol/L (43.3-69.8 nmol/L). Serum 25(OH)D concentrations showed significant variation by parity, smoking, weight, season of sampling, country of birth, and socioeconomic status. After adjustment for maternal and clinical risk factors, low 25(OH)D concentrations were not associated with most adverse pregnancy outcomes. The area under the receiver operating characteristic curve (AUC) and likelihood ratio for a composite of severe adverse pregnancy outcomes of 25(OH)D concentrations <25 nmol/L were 0.51 and 1.44, respectively, and, for risk factors alone, were 0.64 and 2.87, respectively. The addition of 25(OH)D information to maternal and clinical risk factors did not improve the ability to predict severe adverse pregnancy outcomes (AUC: 0.64; likelihood ratio: 2.32; P = 0.39).

CONCLUSION

Low 25(OH)D serum concentrations in the first trimester of pregnancy are not associated with adverse pregnancy outcomes and do not predict complications any better than routinely assessed clinical and maternal risk-factor information.

摘要

背景

一些研究表明,孕妇血清 25-羟维生素 D [25(OH)D]浓度较低与妊娠不良结局有关,但其他研究并未发现这种关联。

目的

我们评估了 10-14 孕周孕妇的血清 25(OH)D 浓度及其与不良妊娠结局的关系,并检验了其预测准确性。

设计

在这项巢式病例对照研究中,我们对在澳大利亚新南威尔士州参加首次孕期筛查的 5109 例单胎妊娠妇女进行了血清 25(OH)D 测量。多变量逻辑回归分析用于检验低 25(OH)D 浓度与不良妊娠结局(胎儿生长受限、早产、子痫前期、妊娠期糖尿病、流产和死胎)之间的关联。评估了模型的预测准确性。

结果

总人群的中位数(IQR)25(OH)D 浓度为 56.4 nmol/L(43.3-69.8 nmol/L)。血清 25(OH)D 浓度随产次、吸烟、体重、采样季节、出生国和社会经济地位而显著变化。在校正了母体和临床危险因素后,低 25(OH)D 浓度与大多数不良妊娠结局无关。25(OH)D 浓度<25 nmol/L 的严重不良妊娠结局综合指标的受试者工作特征曲线(ROC)下面积(AUC)和似然比分别为 0.51 和 1.44,而仅考虑危险因素时,AUC 为 0.64,似然比为 2.87。将 25(OH)D 信息添加到母体和临床危险因素中并未改善预测严重不良妊娠结局的能力(AUC:0.64;似然比:2.32;P=0.39)。

结论

妊娠早期血清 25(OH)D 浓度较低与妊娠不良结局无关,且其预测并发症的效果并不优于常规评估的临床和母体危险因素信息。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验